ZA202204622B - Polypeptide and polypeptide composition for inhibiting and eliminating biofilm formed by helicobacter pylori - Google Patents

Polypeptide and polypeptide composition for inhibiting and eliminating biofilm formed by helicobacter pylori

Info

Publication number
ZA202204622B
ZA202204622B ZA2022/04622A ZA202204622A ZA202204622B ZA 202204622 B ZA202204622 B ZA 202204622B ZA 2022/04622 A ZA2022/04622 A ZA 2022/04622A ZA 202204622 A ZA202204622 A ZA 202204622A ZA 202204622 B ZA202204622 B ZA 202204622B
Authority
ZA
South Africa
Prior art keywords
polypeptide
inhibiting
helicobacter pylori
biofilm formed
composition
Prior art date
Application number
ZA2022/04622A
Inventor
Xiaolin Zhang
Anmin Jiang
Jianfei Wang
Guangming Jin
Qinyuan Zhang
Original Assignee
Univ Anhui Science & Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Anhui Science & Tech filed Critical Univ Anhui Science & Tech
Publication of ZA202204622B publication Critical patent/ZA202204622B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Husbandry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA2022/04622A 2019-10-12 2022-04-25 Polypeptide and polypeptide composition for inhibiting and eliminating biofilm formed by helicobacter pylori ZA202204622B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910966789.9A CN110590914B (en) 2019-10-12 2019-10-12 Honey and polypeptide composition for inhibiting and eliminating helicobacter pylori biofilm formation
PCT/CN2020/085729 WO2021068478A1 (en) 2019-10-12 2020-04-20 Polypeptide and polypeptide composition for inhibiting helicobacter pylori from forming biological membrane and eliminating biological membrane formed by helicobacter pylori

Publications (1)

Publication Number Publication Date
ZA202204622B true ZA202204622B (en) 2022-06-29

Family

ID=68866682

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/04622A ZA202204622B (en) 2019-10-12 2022-04-25 Polypeptide and polypeptide composition for inhibiting and eliminating biofilm formed by helicobacter pylori

Country Status (3)

Country Link
CN (1) CN110590914B (en)
WO (1) WO2021068478A1 (en)
ZA (1) ZA202204622B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110590914B (en) * 2019-10-12 2022-07-19 安徽科技学院 Honey and polypeptide composition for inhibiting and eliminating helicobacter pylori biofilm formation
CN113999285B (en) * 2021-12-02 2023-02-14 浙江大学 Antibacterial heptapeptide and application thereof
CN114478742B (en) * 2022-03-10 2023-07-04 安徽科技学院 Helicobacter pylori resistant active polypeptide and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718618B2 (en) * 2003-10-21 2010-05-18 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
KR100935031B1 (en) * 2007-08-31 2010-01-06 조선대학교산학협력단 Novel synthetic antimicrobial peptide without random coil region and added cationic ion derived from Ribosomal Protein L1 of Helicobacter pylori and composition for antibacterac and antifungal
WO2009046851A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Cgrp as a therapeutic agent
GB201000352D0 (en) * 2010-01-11 2010-02-24 Isogenica Ltd Antimicrobial peptides
CN107556372A (en) * 2017-10-23 2018-01-09 安徽科技学院 Antibacterial peptide with anti Helicobacter pylori activity and the fusion protein comprising the antibacterial peptide
CN108434438B (en) * 2018-06-22 2020-08-25 安徽科技学院 Application of antibacterial peptide in preparation of medicine for treating helicobacter pylori disease and medicine composition
CN110317248B (en) * 2019-06-05 2020-12-29 遵义医科大学珠海校区 Artificially synthesized antibacterial peptide and design method and application thereof
CN110590914B (en) * 2019-10-12 2022-07-19 安徽科技学院 Honey and polypeptide composition for inhibiting and eliminating helicobacter pylori biofilm formation

Also Published As

Publication number Publication date
CN110590914B (en) 2022-07-19
CN110590914A (en) 2019-12-20
WO2021068478A1 (en) 2021-04-15

Similar Documents

Publication Publication Date Title
ZA202204622B (en) Polypeptide and polypeptide composition for inhibiting and eliminating biofilm formed by helicobacter pylori
IL290840A (en) Compositions and methods for cd123 modification
GB201903287D0 (en) Composition
IL290544A (en) Improved methods for making organoid compositions
PL3634444T3 (en) Compositions for use in the treatment of helicobacter pylori
IL288024A (en) Methods and compositions for preventing type
EP4079786A4 (en) Curable composition
GB202004460D0 (en) Herbical composition
IL284327A (en) Compositions and methods for inhibiting hmgb1 expression
GB202115101D0 (en) Composition
GB202007377D0 (en) Composition
SG11202101920WA (en) Composition for eradicating helicobacter pylori
EP4079516A4 (en) Curable composition
SG11202110390XA (en) Composition
KR102216170B9 (en) Coating resin composition for preventing dew
IL290325A (en) Biopharmacuetical compositions and related methods
GB2584141B (en) Compositions and methods for waterproofing applications
GB202211772D0 (en) Composition
EP3886884A4 (en) Compositions and methods for treating and preventing helicobacter pylori infections
GB201905390D0 (en) Compounds and compositions
GB201804965D0 (en) Improved PBX composition
GB2605389B (en) Composition
EP4067394A4 (en) Curable composition
GB2583379B (en) Composition
PL3997166T3 (en) Curable composition